Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2008

Conditions
Chronic Lymphocytic Leukemia
Interventions
PROCEDURE

Autologous stem cell transplantation

TBI (10 grays, d-3-1), cyclophosphamide (60 mg/sqm d-5-4)

PROCEDURE

DHAP rescue and Autologous stem cell transplantation

DHAP :IV cisplatin 100 mg/sqm d1, IV cytarabine 2 g/sqm d2,, IV dexamethasone 40 mg/sqm d1-4, TBI (10 grays d-3-1), cyclophosphamide (60 mg/sqm d-5-4)

PROCEDURE

DHAP rescue and F+C

DHAP :IV cisplatin 100 mg/sqm d1, IV Cytarabine 2 g/sqm d2, IV dexamethasone 40 mg/sqm d1-4, Followed by 3 monthly cycles with IV d1-3 fludarabine (25 mg/sqm) \& cyclophosphamide (300 mg/sqm)

Trial Locations (1)

75000

DBIM Hopital Saint Louis, Paris

All Listed Sponsors
collaborator

Direction Générale de la Santé, France

OTHER

lead

University Hospital, Caen

OTHER

NCT00931645 - Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter